ENTESCENCE Trademark

Trademark Overview

On Friday, February 28, 2014, a trademark application was filed for ENTESCENCE with the United States Patent and Trademark Office. The USPTO has given the ENTESCENCE trademark a serial number of 79146442. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Wednesday, February 28, 2024. This trademark is owned by INSTITUT GUSTAVE-ROUSSY. The ENTESCENCE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical products, namely, pharmaceutical preparations for the treatment of cancer; bio-pharmaceutical products excluding essential oils, namely, animal and plant extracts for the treatment of cancer; diagnostic products for medical use, namely, diagnostic preparations for medical purposes, medical diagnostic reagents

Research services in the fields of biology, chemistry, in the medical field
entescence

General Information

Serial Number79146442
Word MarkENTESCENCE
Filing DateFriday, February 28, 2014
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateWednesday, February 28, 2024
Registration Number4741275
Registration DateTuesday, May 26, 2015
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 10, 2015

Trademark Statements

Goods and ServicesPharmaceutical products, namely, pharmaceutical preparations for the treatment of cancer; bio-pharmaceutical products excluding essential oils, namely, animal and plant extracts for the treatment of cancer; diagnostic products for medical use, namely, diagnostic preparations for medical purposes, medical diagnostic reagents
Translation of Words in MarkThe wording "ENTESCENCE" has no meaning in a foreign language.
Goods and ServicesResearch services in the fields of biology, chemistry, in the medical field

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 10, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 10, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameINSTITUT GUSTAVE-ROUSSY
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressVILLEJUIF CEDEX F94805
FR
Party NameINSTITUT GUSTAVE-ROUSSY
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressVILLEJUIF CEDEX F94805
FR
Party NameINSTITUT GUSTAVE-ROUSSY
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressVILLEJUIF CEDEX F94805
FR

Trademark Events

Event DateEvent Description
Thursday, May 8, 2014SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, May 12, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, May 16, 2014APPLICATION FILING RECEIPT MAILED
Friday, June 6, 2014ASSIGNED TO EXAMINER
Monday, June 9, 2014NON-FINAL ACTION WRITTEN
Tuesday, June 10, 2014NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 10, 2014REFUSAL PROCESSED BY MPU
Wednesday, June 11, 2014NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, June 27, 2014REFUSAL PROCESSED BY IB
Thursday, November 20, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, November 20, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 21, 2014ASSIGNED TO LIE
Tuesday, December 2, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 2, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, January 15, 2015LIMITATION OF GOODS RECEIVED FROM IB
Thursday, January 22, 2015LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Thursday, January 29, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 30, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, February 18, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 18, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 18, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, March 6, 2015NOTIFICATION PROCESSED BY IB
Tuesday, March 10, 2015PUBLISHED FOR OPPOSITION
Tuesday, March 10, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, April 20, 2015ASSIGNED TO EXAMINER
Tuesday, May 26, 2015REGISTERED-PRINCIPAL REGISTER
Wednesday, August 26, 2015FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, September 24, 2015FINAL DISPOSITION PROCESSED
Thursday, September 24, 2015FINAL DISPOSITION NOTICE SENT TO IB
Friday, October 30, 2015FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, January 23, 2020NEW REPRESENTATIVE AT IB RECEIVED
Thursday, February 6, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 26, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 10, 2021CANCELLED SECTION 71
Wednesday, August 10, 2022TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, September 22, 2022INVALIDATION PROCESSED
Thursday, September 22, 2022TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sunday, October 16, 2022TOTAL INVALIDATION PROCESSED BY THE IB
Monday, December 19, 2022NEW REPRESENTATIVE AT IB RECEIVED
Friday, January 13, 2023NEW REPRESENTATIVE AT IB RECEIVED
Friday, October 27, 2023NEW REPRESENTATIVE AT IB RECEIVED
Friday, September 20, 2024DEATH OF INTERNATIONAL REGISTRATION
Friday, September 20, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED

Related Keywords

entescence medical pharmaceutical diagnostic namely products treatment preparations cancer services research